Pharma Innovation & Market Dynamics

As physician shortages deepen, osteopathic doctors (DOs) are rapidly expanding their ranks & focusing on holistic, patient-centered care – particularly in underserved communities. A look at the growing influence of DOs.

After 35+ years serving Doylestown, Dr. Terry Rakowsky transitions his practice to Dr. Sean Brown, prioritizing patient continuity & community ties amidst a shifting dental landscape.

A new partnership between Freedom Surgical Center and Olena Medical signals a growing trend toward specialized outpatient care and a renewed focus on patient-centered anesthesia. Is this a model for the future?

Biotech firm Akebia Therapeutics is recalibrating its growth strategy after the FDA signaled concerns over the size of a planned trial for its anemia drug, Vafseo, impacting patients and investors.

Jazz Pharmaceuticals’ appointment of former Global Blood Therapeutics CEO Ted Love to its board, coupled with a long-serving director's retirement, points to a potential strategic reset for the growing pharma company.

A decade-long collaboration expands as Sanofi adopts Medidata’s AI-powered platform to streamline clinical development, embrace decentralized trials, and potentially unlock faster access to new therapies.

Nutriband Inc. receives positive FDA feedback on its AVERSA™ FENTANYL patch, a novel approach to combating opioid misuse. The company is poised to enter clinical trials with a potential peak US market of $80-$200 million.